baber/WOPTO huggingface dataset:
Patent EA-011839-B1 (EA)
Title: Wireless exploration seismic system
Inventor: CRISE DOUGLAS
IPC: G01V1/00
Filed: 2006-10-05
Abstract: Systems and methods are provided for acquiring seismic data using a wireless network and a number of individual data acquisition modules that are configured to collect seismic data and forward data to a central recording and control system. In one implementation, a number of remote modules (301) are arranged in lines. Base station modules (302) receive information from the lines and relay the information to a central control and recording system (303). Radio links operating on multiple frequencies (F1-F12) are used by the modules (301). For improved data transfer rate, radio links from a remote module (301) leap past the nearest remote module to the next module closer to the base station.
Patent EA-017860-B1 (EA)
Title: Multimer for immunostimulation
Inventor: SCHROFF MATTHIAS
IPC: C12N15/117
Filed: 2007-05-11
Abstract: The invention relates to a multimeric non-coding nucleic acid molecule for modulating the activity of the human or animal immune system, and to a preparation process therefor and a vaccine which comprises the multimeric non-coding nucleic acid molecule.
Patent EA-015516-B1 (EA)
Title: Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Inventor: LI RENHUA
IPC: A61K31/4015
Filed: 2007-04-24
Abstract: The present invention discloses novel compounds of Formula I,having 11Beta-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11Beta-HSD type 1 activity.
Patent EA-014209-B1 (EA)
Title: Cut resistant yarn and products containing the yarn
Inventor: MARISSEN ROELOF
IPC: D01F1/10
Filed: 2007-09-06
Abstract: Cut resistant yarn the yarn containing filaments and/or staple fibers, the filaments and/or staple fibers containing a hard component to improve cut resistance of the yarn, wherein the hard component is a plurality of hard fibers having an average diameter of at most 25 microns and also a product containing such yarn.
Patent EA-016107-B1 (EA)
Title: Plant and method for dry extracting / cooling heavy ashes and for controlling the combustion of high unburnt content residues
Inventor: MAGALDI MARIO
IPC: F23C7/00
Filed: 2007-02-20
Abstract: The present invention relates to a system for dry extracting / cooling heavy ashes and for controlling the combustion of high unburnt content residues, allowing to: extract heavy ash from the boiler bottom (12), foster and adjust post-combustion on the extractor belt (14) by combined use of comburent hot air and inert combustion fumes, already available in boiler, cool the ashes present on the belt and optionally re- circulating them - all or in part - in boiler, along with the fraction of light ashes of higher unburnt content.
Patent EA-022736-B1 (EA)
Title: Method for producing endothelial cells (variants)
Inventor: KISELJOV SERGEJ L VOVICH
IPC: C12N5/07
Filed: 2008-12-24
Abstract: The invention relates to bioengineering, in particular to producing endothelial cells from human embryonal stem cells and to the use thereof. The inventive method for producing endothelial cells from human embryonal stem cells involves differentiating human embryonal stem cells on a substrate and in a synthetic medium which provide the oriented direct differentiation of human embryonal stem cells into endothelial cells based on the mixture of DMEM/FI2 and a KO serum substitute having VEGF, SCF, BMP4, bFGF and TGFbeta growth factors and taken in effective quantities, wherein TGFbeta is added on 3rd-6th day of differentiation. A differentiation medium based on the mixture of DMEM/FI2 with fetal bovine serum having VEGF, SCF and bFGF growth factors can be also used. The separation is carried out on 3rd-9th day according to an immunological selection method using markers specific for endothelial cells and, afterwards, the thus produced endothelial cells are cultivated in the above-mentioned medium with an inoculum density which is equal to or greater than 50000 cells per 1 cm.
Patent EA-019089-B1 (EA)
Title: Electric-grade wire from aluminium alloy
Inventor: ANIKEEV YURY GEORGIEVICH
IPC: B21C1/00
Filed: 2010-10-04
Abstract: The invention relates to metal forming process, in particular to producing wire by continuous drawing, wherein such wire is produced from an aluminium alloy meeting by its physical and mechanical properties big loads to tensile fracture and large electroconductivity. The inventive result is aimed at the use thereof in metallurgy and in electrotechnical industry and also provides improved higher surface microcontinuity and electroconductivity strength. An electrode wire produced from an aluminium alloy is characterized in that it comprises a core enveloped by a reinforced microcontinuity layer obtained by a plastic surface deformation of a billet wire, the density and microconductivity of which exceed those of the aforesaid core, tensile strength is 16-18 kgf/mmand alloy comprises wt%: iron 0.5-0.7; silicon 0.2-0.4; cerium, lanthanum, praseodymium totally 6.0-10.0; admixtures 0.1-0.3; aluminium making the rest.
Patent EA-020096-B1 (EA)
Title: Use of pharmaceutical composition for treating and preventing late gestosis forms
Inventor: DOROVSKIJ ALEXANDER VIKTOROVICH
IPC: A61K9/08
Filed: 2010-01-20
Abstract: The invention relates to medicine, in particular, to a novel use of a pharmaceutical composition, comprising an active substance (S)-2-amino-5 guanidinopentanoic acid (S)-2-aminoglutarate for the treatment and prevention of late gestosis forms. The use of the pharmaceutical composition, comprising an active substance (S)-2-amino-5 guanidinopentanoic acid (S)-2-aminoglutarate and, at least, one pharmaceutically acceptable auxiliary substance and/or a solvent, for the treatment and prevention of gestosis late forms, wherein the composition administered intravenously first twice a day injecting once 1 dose of 2 g of the active substance during 5-7 days; then the composition is administered orally in a tableted form by 2-3 tablets 2-3 times a day comprising 0,25 g/dose or by 1 tablet 3 times a day comprising 0,75 g/dose. Thus, the claimed invention provides to reduce the rate of late gestosis development, to stop growing gestosis into serious forms, that is to carry out the treatment and prevention of late gestosis forms.
Patent EA-027333-B1 (EA)
Title: Room temperature stable non-crystalline aspirin
Inventor: OVOKAITYS TODD F
IPC: C07C69/00
Filed: 2008-10-16
Abstract: The present invention provides stable non-crystalline aspirin that does not crystallize at room temperature during storage for prolonged periods of time and processes for obtaining the stable non-crystalline aspirin.
Patent EA-020300-B1 (EA)
Title: Method and system of cleaning and flushing a beverage dispensing system
Inventor: RASMUSSEN JAN NOERAGER
IPC: B67D1/07
Filed: 2009-09-10
Abstract: A method and a system of cleaning and flushing a beverage dispensing system comprising a sealable pressure chamber for receiving a collapsible keg containing a beverage and a dispensing valve, comprises: (i) providing a first cartridge containing a cleaning fluid, (ii) positioning the first cartridge in the pressure chamber and pressurising the pressure chamber, (iii) opening the dispensing valve and dispensing the cleaning fluid from the dispensing valve, and causing the cleaning fluid to flow from the first cartridge through the dispensing line and being dispensed from the dispensing valve, (iv) disconnecting the first cartridge after the emptying of the cleaning fluid from the first cartridge, and removing the first cartridge, (v) providing a second cartridge containing a flushing fluid, (vi) positioning the second cartridge in the pressure chamber and pressurising the pressure chamber, and repeating the steps (iii)-(v) while using the second cartridge instead of the first cartridge.
Patent EA-021763-B1 (EA)
Title: Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
Inventor: PARK JAE HYUN
IPC: A61P25/28
Filed: 2009-06-05
Abstract: The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising granular forms of amlodipine and losartan which are separated from each other, and a stabilizing agent, which has improved storage stability due to minimized interaction between amlodipine and losartan.
Patent EA-022001-B1 (EA)
Title: Systems and methods for real time data management in a collaborative environment
Inventor: PAULK MARTIN D
IPC: G06Q10/02
Filed: 2010-02-24
Abstract: Systems and methods for real time data management in a collaborative environment. In one embodiment, the systems and methods dynamically link stakeholders, through a collaborative environment, to current and updated data. The systems and methods also cross-reference data objects between stakeholders for calling data objects by a common name, and determine a preferred method for each operation related to processing data for a data object.
Patent EA-020399-B1 (EA)
Title: Method of volume batching
Inventor: PITSAEV MUKHTAR ALIEVICH
IPC: G01F13/00
Filed: 2012-01-30
Abstract: The invention relates to methods of cycling volume batching of bulk materials, preferably for dosing such product as roasted seeds before being packed in the presence of a buyer and sale. The technical result is aimed at providing accuracy of volume batching, reduction of power consumption, simplicity of method implementation. The method is characterized in that it comprises supplying a product from a bunker into a measured capacity of rated volume during fixed time, filling the volume and feeding the measured product dose to discharge position, the dose in the measured capacity formed by impeller vanes is cut-off by a dose cut-off plate made consisting of a set of plates made from different plastic materials, wherein product is supplied continuously into the measured capacity, the product is supplied from the bunker to the discharge position is carried out using gravity forces and the impeller rotation, wherein an amount of the discharged product is controlled by an electronic counter. The use of the proposed invention provides to increase the accuracy of volume batching, to make easier control of the discharged product through the apparatus, to reduce power consumption, thus resulting to improve the production efficiency.
Patent EA-022246-B1 (EA)
Title: Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy
Inventor: HEYNE KARSTEN
IPC: G01N21/3504
Filed: 2010-12-21
Abstract: The invention relates to a measuring device and to a method for analysing a test gas by means of an infrared absorption spectroscopy. Said measuring device comprises a measurement chamber (2) containing test gas which is to be analysed, a laser (1) which is arranged in relation to the measurement chamber (2) such that the light emitted by the laser traverses the measurement chamber (2), a detection device (61) which detects the light emitted by the laser (1) and traversing the measurement chamber (2), and an evaluation unit (8) which evaluates the signals generated by the detection device (61) for determining light absorption in the measurement chamber (2). The detection device (61) carries out an individual absorption measurement within a time span of 10s or faster and also is suitable and adjustable for measuring test gas which is in the form of a respiratory gas of a human or animal, wherein said respiratory gas being replaced in the measurement chamber only under the respiration effect of humans or animals.
Patent EA-021979-B1 (EA)
Title: Forming a shaft for an underground mine
Inventor: WEBB ROCKY LYNN
IPC: E21D1/03
Filed: 2010-06-30
Abstract: In forming a mine shaft for an underground mine, earth excavated by a boring machine (21) is transported upwardly by handling unit (22) to a transfer station (33) where it is transferred into skips (36) which are raised and lowered along skip guides (38) within the shaft hole (19) for transport of the excavated material to an earth surface region. Transfer station (33) is moved downwardly as excavation progresses.
Patent EA-023923-B1 (EA)
Title: Inhibitors of glucosylceramide synthase
Inventor: LIU HARLIN
IPC: C07D405/06
Filed: 2010-11-24
Abstract: The hemitartrate salt of a compound represented by the following structural formula:(Formula I Hemitartrate), which may be used in pharmaceutical applications; particular single crystalline forms of the Formula (I) Hemitartrate characterized by a variety of properties and physical measurements are disclosed. Methods of producing crystalline Formula (I) Hemitartrate, and using it to inhibit glucosylceramide synthase or lowering glycosphingolipid concentrations in subjects to treat a number of diseases, are also discussed. Pharmaceutical compositions are also described.
Patent EA-022265-B1 (EA)
Title: Method and device for reducing nitrosamines which form during removal of cofrom flue gases using an aqueous amine solution
Inventor: MENZEL JOHANNES
IPC: C01B32/40
Filed: 2011-12-12
Abstract: The invention relates to a method for reducing nitrosamines which form during removal of COfrom flue gases using an aqueous amine solution. According to the invention a subquantity of the aqueous amine solution that is loaded with nitrosamines is branched off from a scrubbing liquid circuit and concentrated by vaporizing water and low-boiling constituents. The concentrated amine solution stays at boiling temperature in an apparatus in which a liquid phase and a vaporous phase are in contact and a vapour/liquid equilibrium is established between the phases. The vaporous phase is irradiated with UV light within the apparatus, which UV light decomposes nitrosamines transferring to the vaporous phase. The concentrated amine solution is returned to the scrubbing liquid circuit after the treatment in the apparatus. The invention also relates to a plant for carrying out the method.
Patent EA-027201-B1 (EA)
Title: Optical cable having removable micromodules and an inner longitudinal profile member
Inventor: JAMET PATRICK
IPC: G02B6/44
Filed: 2012-12-03
Abstract: The invention relates to a cable (1) with retrievable micromodules (6) passing in longitudinal direction (X) containing an internal lengthwise profile (3) for division into compartments and outer shell (2), wherein the internal lengthwise profile (3) for division into compartments limits by jointing together with the outer shell (2) at least two compartments (4.1, 4.2, 4.3, 4.4), wherein at least in one of the compartments (4.1, 4.2, 4.3, 4.4) there is at least one of micromodules (6).
Patent EA-028130-B1 (EA)
Title: Dual-valve contrast fluid delivery system
Inventor: PETERS JEAN-PIERRE
IPC: A61M39/26
Filed: 2011-07-15
Abstract: A disposable set (5) for establishing a fluid connection between a fluid dispensing unit (17) and a dosing device adapted to dispense the fluid into a patients vein, the disposable set comprising a length of a tubing (15) for establishing a fluid connection from the fluid dispensing unit towards and into the dosing device, wherein the tubing (15) comprises a first 10 (1) and a second (10) tubing part, and a releasable connection (11,12), wherein the first tubing part (1) comprises two or more one-way valves (3, 24) which are provided to prevent a backflow from the patient in the direction of the fluid dispensing unit (17) in the closed position of the releasable connection.
Patent EA-036454-B1 (EA)
Title: Sprinkler system with a sprinkler extending into the centre of a pipeline
Inventor: GARDEN IAN
IPC: B05B15/65
Filed: 2013-07-09
Abstract: A nozzle system comprising a nozzle apparatus (610) and a pipeline (614), the nozzle apparatus attached to the pipeline such that there is fluid communication therebetween, the nozzle apparatus having a first inlet (631), a second inlet (622) and an outlet, wherein the nozzle apparatus extends into the pipeline such that at least a portion of the first inlet (631) is in the centre of the pipeline, that is within 15% of the central axis of the pipeline; and the second inlet (622) is within the pipeline but out with the centre of the pipeline, the second inlet comprising a filter with at least one, normally at least four, linear apertures (625) therein, often parallel to a main axis of the nozzle apparatus (610). Preferably the first inlet is a larger aperture than the second inlet, and is provided on an end of the nozzle apparatus and the second inlet is provided on a side of the nozzle apparatus. An advantage of certain embodiments of the invention is that where debris builds upon an inside face of the pipeline (concentric corrosion), fluid can still flow through the inlet provided in the centre of the pipeline, and so nozzle apparatus as described herein are less liable to blockages.
Patent EA-029588-B1 (EA)
Title: Coated pane having areas in which the coating is partially removed
Inventor: WOHLFEIL DIRK
IPC: H01Q15/00
Filed: 2013-08-20
Abstract: A coated pane having a communication window (7), at least comprising: a. a base pane (1), b. a coating (2) containing metal, c. a first grid plane (3.1) and a second grid plane (3.2) within the coating (2) containing metal, d. wherein the first grid plane (3.1) and the second grid plane (3.2) have areas in which the coating is removed, in form of grid lines (4.1, 4.2) arranged in the manner of a mesh, e. the grid lines (4.1) in the first grid plane (3.1) on at least one long side transition into an open comb structure (6) having teeth (5) and the grid lines (4.2) in the second grid plane (3.2) on at least one long side transition into a closed comb structure (8), wherein f. the first grid plane (3.1) is connected by means of at least one tooth (5) of the open comb structure (6) to the closed comb structure (8) of the second grid plane (3.2).
Patent EA-028031-B1 (EA)
Title: Solid form of dihydro-pyrido-oxazine derivative
Inventor: HURTH KONSTANZE
IPC: C07D498/04
Filed: 2013-11-26
Abstract: The invention relates to an anhydrous crystalline form of (1,1-dioxo-hexahydro-1lambda*6*-thiopyran-4-yl)-{(S)-3-[1-(6-methoxy-5-methyl-pyridin-3-yl)-2,3-dihydro-1H-pyrido[3,4-b][1,4]oxazin-7-yloxy]pyrrolidin-1-yl}methanone; pharmaceutical compositions and combinations including these forms as well as to methods of using these forms, including their pharmaceutical compositions and combinations for the treatment of diseases.
Patent EA-028402-B1 (EA)
Title: Quinolone derivatives
Inventor: DESAI RANJIT C
IPC: C07D491/04
Filed: 2013-12-23
Abstract: The present invention relates to novel compounds of the general formula (I), pharmaceutical compositions containing said compounds, use of these compounds for the treatment of conditions mediated by HIF prolyl hydroxylase and a method for the treatment of anemia comprising administering the claimed compounds.
Patent EA-027227-B1 (EA)
Title: Method for manufacturing molded material
Inventor: NAKAMURA NAOFUMI
IPC: B21D24/00
Filed: 2014-11-07
Abstract: A formed material having a tubular body and a flange formed at an end of the body is manufactured by multistage drawing of a blank metal sheet. The multistage drawing includes preliminary drawing in which a preliminary body having a body preform is formed from the blank metal sheet, and at least one compression drawing which is performed after the preliminary drawing and in which the body is formed by drawing the body preform while applying a compressive force to the body preform. The at least one compression drawing is performed so as to be completed before the pad portion of pressurization means reaches bottom dead center, and a support force supporting the pad portion acts as the compressive force upon the body preform when the body preform is drawn.
Patent EA-037142-B1 (EA)
Title: Mutated allene oxide synthase 2 (aos2) genes
Inventor: GUNAWARDENA UVINI
IPC: A01H5/00
Filed: 2014-03-14
Abstract: Provided are compositions and methods relating to gene and/or protein mutations in plants. In certain embodiments, the invention relates to mutations in the allene oxide synthase 2 gene (i.e., AOS2). In some embodiments, the invention relates to plants that are pathogen resistant.
Patent EA-034676-B1 (EA)
Title: Novel anti-netrin-1 antibody
Inventor: DELCROS JEAN-GUY
IPC: A61K39/395
Filed: 2015-01-09
Abstract: The invention provides an antigenic polypeptide comprising a linear epitope of netrin-1. This polypeptide has sequence SEQ ID NO: 3, or sequence having at least 95% of identity to SEQ ID NO: 3, or is a fragment of sequence SEQ ID NO: 3 comprising sequence SEQ ID NO: 35, or sequence having at least 95% of identity to SEQ ID NO: 35 or encoded by the cDNA of sequence SEQ ID NO: 4, or a variant thereof by virtue of the degeneracy of the genetic code, or sequence having at least 95% of identity to SEQ ID NO: 4. Said antigenic polypeptide is able to generate an antibody that specifically binds to the linear epitope of netrin-1 in sequence SEQ ID NO: 3 or SEQ ID NO: 35. Thus, the present invention further relates to the use of the antigenic polypeptide to produce antibodies binding to netrin-1 and to the antibodies so produced that are able to induce cell death or apoptosis of tumor cells via UNC5 receptors or DCC receptors. The invention also provides a pharmaceutical composition for treating cancer, wherein cancer cells or stromal cells express netrin-1, comprising an antibody by the invention and a pharmaceutically acceptable vehicle, carrier or diluent.
Patent EA-032581-B1 (EA)
Title: Heteroaryl substituted heterocyclyl sulfones
Inventor: SCHUNK STEFAN
IPC: C07D405/04
Filed: 2015-04-14
Abstract: The invention relates to aryl substituted heterocyclyl sulfones of general formula (I)as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Patent EA-032995-B1 (EA)
Title: Method for removal of a polymer film roll wound without a core from a mandrel
Inventor: IVANOV ALEXANDER SERGEEVICH
IPC: B65H67/00
Filed: 2017-08-28
Abstract: The proposed technical solution relates to polymer film rewinding from large rolls to smaller rolls that are suitable for wrap-packing of various goods and cargoes, wherein the rolled film is wound, without a core, directly to a rewinding assembly mandrel, and may be used in hand-operated and machine wrapping devices. The method for removal of a polymer film roll wound without a core from a mandrel includes pushing the polymer film roll wound without a core off the mandrel having a perforated wall, wherein, when the roll is being pushed off, water-air mixture is pressure-fed via the mandrel perforated wall, which results in enlargement of the roll internal diameter. The claimed invention is aimed at achieving the technical results consisting in lower power consumption due to lower compressed air consumption, and also higher speed of the roll removal from the mandrel and improved condition of the roll after removal due to lower friction between the roll internal surface and the mandrel surface.